Recall Register

Nipro Renal Soultions USA, Corporation: FDA recalls

Newest recall start date in this list: . MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201

FDA enforcement events from 2024 to 2026; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Nipro Renal Soultions USA, Corporation as the recalling firm in 3 events. The events have 6 product records. The recalls started from 2024 to 2026. All the events are device recalls. By FDA enforcement events, Nipro Renal Soultions USA, Corporation is number 1,114 of 1,629 firms that have a page. Events that Nipro Renal Soultions USA, Corporation started: 1 in 2024 and 1 in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

3 events, newest first.

FDA enforcement events of Nipro Renal Soultions USA, Corporation
InitiatedProduct (first record)TypeClassRecordsStatus
5 Aug 2026MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201DeviceClass II4Ongoing
11 Apr 2025MedicaLyte Liquid Bicarbonate Concentrate. Model Numbers: BC+201 (45X), BC+100 36.83X. Plastic bottle packaged in corrugated shipper cases (4 bottles per shipper case).DeviceClass I1Ongoing
22 Nov 2024Citric Complete - Dry Citric Acid Concentrate Model Number: DCA+225-25DeviceClass II1Ongoing

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

Nipro Renal Soultions USA, Corporation: events for each product type
TypeEvents
Device3
Nipro Renal Soultions USA, Corporation: events in each class
ClassEvents
Class II2
Class I1
Share of the events of the firm in Class I
33%
Share of all events on the register in Class I
18%
Events with the status Ongoing
3

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Nipro Renal Soultions USA, Corporation, by the year that the recall started. The largest year is 2024, with 1 event.

Official channels

Cite this page

Recall Register. Nipro Renal Soultions USA, Corporation: FDA recalls. https://recallregister.com/firm/nipro-renal-soultions-usa-corporation/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
PA

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Nipro Renal Soultions USA, Corporation have?
Class II: 2 events. Class I: 1 event. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of Nipro Renal Soultions USA, Corporation?
FDA event 99573, which the firm started on 5 Aug 2026. The first product in the record is: MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201
How many FDA recalls of Nipro Renal Soultions USA, Corporation have the status Ongoing?
3 events have the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.